A nomogram for predicting the risk of Clostridioides difficile infection in children with ulcerative colitis:

Ziying Li1,2, Fumin Xue1, Jing Zhang3

  • 1Department of Gastroenterology, Children's Hospital Affiliated to Zhengzhou University, Zhengzhou, Henan, China.

Frontiers in Pediatrics
|October 27, 2025
PubMed

Insights

A new nomogram model predicts Clostridioides difficile infection (CDI) risk in pediatric ulcerative colitis (UC) patients. Key factors include PUCAI, ESR, Vitamin D, fecal calprotectin, and antibiotic duration, aiding early diagnosis.

Area of Science:

  • Pediatric Gastroenterology
  • Infectious Diseases
  • Clinical Informatics

Background:

  • Clostridioides difficile infection (CDI) is a significant concern in pediatric inflammatory bowel disease.
  • Ulcerative colitis (UC) patients are at increased risk for CDI, complicating management.
  • Predictive tools for CDI in pediatric UC are limited, necessitating further research.

Purpose of the Study:

  • To develop and validate a dynamic nomogram model for predicting CDI risk in children with UC.
  • To identify independent risk factors associated with CDI development in this population.
  • To provide a clinical tool for early CDI detection and management adjustment.

Main Methods:

  • Retrospective study of 121 pediatric UC patients (2018-2024).
  • Patients categorized into CDI (n=35) and non-CDI (n=86) groups.
  • LASSO and multivariate logistic regression identified risk factors; nomogram constructed and validated (ROC, calibration, DCA, bootstrap).

Main Results:

  • Five independent risk factors for CDI identified: Pediatric Ulcerative Colitis Activity Index (PUCAI), erythrocyte sedimentation rate (ESR), vitamin D (Vit D), fecal calprotectin (FC), and antibiotic use >7 days.
  • The nomogram demonstrated excellent discriminative ability (C-index = 0.964).
  • Model showed good concordance, significant clinical benefit, and robust consistency across subgroups.

Conclusions:

  • PUCAI, ESR, Vit D, FC, and prolonged antibiotic use are key predictors of CDI in pediatric UC.
  • The developed nomogram facilitates early CDI diagnosis in children with UC.
  • This tool supports timely therapeutic strategy adjustments for improved patient outcomes.
Abstract

Related Concept Videos

Dosage Regimen Designs: Nomograms and Tabulations01:23

Dosage Regimen Designs: Nomograms and Tabulations

Nomograms and tabulations are vital tools used by clinicians to design accurate and individualized dosage regimens. These instruments provide a straightforward method for adjusting dosages based on individual patient characteristics, including age, weight, and physiological condition. The foundation of a drug's nomogram is population pharmacokinetic data collected and analyzed using specific models. This data simplifies complex equations, presenting them diagrammatically or tabularly for easy...
174
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
882
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
248